Daniel Wilson
Conseiller Juridique Général chez DYNE THERAPEUTICS, INC.
Postes actifs de Daniel Wilson
Sociétés | Poste | Début | Fin |
---|---|---|---|
DYNE THERAPEUTICS, INC. | Conseiller Juridique Général | 01/06/2020 | - |
Historique de carrière de Daniel Wilson
Anciens postes connus de Daniel Wilson
Sociétés | Poste | Début | Fin |
---|---|---|---|
CELGENE | Conseiller Juridique Général | 01/01/2012 | 01/01/2020 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - | - |
Formation de Daniel Wilson
Swarthmore College | Undergraduate Degree |
University of Pennsylvania | Graduate Degree |
Boston University School of Law | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
General Counsel | 2 |
Graduate Degree | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
DYNE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Bourse
- Insiders
- Daniel Wilson
- Expérience